BAX
Baxter International Inc.
Price Chart
Latest Quote
$19.39
-1.07 (-5.23%)
Current Price
| Previous Close | $20.46 |
| Open | $20.42 |
| Day High | $20.62 |
| Day Low | $19.38 |
| Volume | 5,307,939 |
Stock Information
| Quarterly Dividend / Yield | $0.20 / 0.98% |
| Shares Outstanding | 516.47M |
| Quarterly Dividend Yield | 0.98% |
| Quarterly Dividend | $0.20 |
| Total Debt | $9.69B |
| Cash Equivalents | $2.02B |
| Revenue | $11.32B |
| Net Income | $-981.00M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $10.01B |
| EPS (TTM) | $-1.91 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $18.21B |
| Sales | $11.32B |
| Income | $-981.00M |
| Book/sh | $11.70 |
| Cash/sh | $3.91 |
| Employees | 38K |
Financial Ratios
| Quick Ratio | 1.02 |
| Current Ratio | 1.85 |
| Debt/Eq | 161.02 |
Returns & Margins
| ROA | 2.85% |
| ROE | -15.01% |
| Gross Margin | 34.65% |
| Operating Margin | 6.03% |
| Profit Margin | -9.70% |
Ownership
| Insider Ownership | 0.34% |
| Institutional Ownership | 106.53% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 9.63 |
| PEG | 36.68 |
| P/S | 0.88 |
| P/B | 1.66 |
Analyst Data
| Recommendation | hold |
| Target Price | $21.54 |
Technical Indicators
| SMA20 | $19.48 |
| SMA50 | $18.42 |
| SMA200 | $19.68 |
| RSI | 51.41 |
| ATR | 0.7214 |
| Shares Float | 513.97M |
| Short Float | 12.96% |
| Short Ratio | 5.27 |
| Volatility | 0.64 |
| Rel Volume | 0.77 |
Performance History
| Week | -4.53% |
| Month | +9.05% |
| Quarter | +13.52% |
| 6 Months | -0.62% |
| YTD | -0.46% |
| Year | -36.55% |
| 3 Years | -51.68% |
| 5 Years | -74.48% |
| 10 Years | -49.58% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $19.39 | 5,307,939 |
| 2026-06-16 | $20.46 | 6,841,100 |
| 2026-06-15 | $20.81 | 6,022,400 |
| 2026-06-12 | $20.86 | 7,622,400 |
| 2026-06-11 | $20.49 | 7,528,500 |
| 2026-06-10 | $20.31 | 11,725,700 |
| 2026-06-09 | $20.03 | 6,493,100 |
| 2026-06-08 | $19.24 | 5,044,300 |
| 2026-06-05 | $19.38 | 6,838,800 |
| 2026-06-04 | $19.35 | 5,959,700 |
| 2026-06-03 | $18.54 | 4,591,100 |
| 2026-06-02 | $18.68 | 5,980,600 |
| 2026-06-01 | $18.40 | 8,560,400 |
| 2026-05-29 | $18.78 | 8,486,400 |
| 2026-05-28 | $19.24 | 5,025,300 |
| 2026-05-27 | $19.32 | 8,549,900 |
| 2026-05-26 | $19.37 | 5,290,400 |
| 2026-05-22 | $19.17 | 7,219,800 |
| 2026-05-21 | $19.02 | 8,756,600 |
| 2026-05-20 | $18.76 | 6,801,200 |
| 2026-05-19 | $18.32 | 5,663,100 |
| 2026-05-18 | $17.78 | 6,251,900 |
About Baxter International Inc.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
đ° Latest News
Reasons to Retain Baxter International Stock in Your Portfolio for Now
Zacks âĸ 2026-06-16T18:14:00Z
Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value Warranted
Simply Wall St. âĸ 2026-06-15T01:11:07Z
Baxter International (BAX) Stock Valuation Check After Recent Double Digit Gains And Ongoing Turnaround Plans
Simply Wall St. âĸ 2026-06-14T18:04:52Z
3 Unpopular Stocks Weâre Skeptical Of
StockStory âĸ 2026-06-12T12:13:20Z
Is Baxter International Inc. (BAX) A Good Stock To Buy Now?
Insider Monkey âĸ 2026-06-11T20:14:52Z
DaVita Stock Gains From Integrated Kidney Care and CKCC Progress
Zacks âĸ 2026-06-10T16:54:00Z
Baxter International (BAX) Faces Tough Road Ahead, Says Citi in Downgrade
Insider Monkey âĸ 2026-06-10T04:01:24Z
FMS and Home Dialysis: How 5008X Could Reset Demand
Zacks âĸ 2026-06-08T18:51:00Z
Why Baxter (BAX) Shares Are Sliding Today
StockStory âĸ 2026-05-29T00:38:00Z
Has Baxter International (BAX) Overreacted After Recent 10.9% Weekly Share Price Jump
Simply Wall St. âĸ 2026-05-24T06:11:14Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $7,865,000,000 | $6,652,000,000 | $6,210,000,000 | $6,508,000,000 |
| Cost Of Revenue | $7,865,000,000 | $6,652,000,000 | $6,210,000,000 | $6,508,000,000 |
| Total Revenue | $11,244,000,000 | $10,636,000,000 | $10,360,000,000 | $10,057,000,000 |
| Operating Revenue | $11,244,000,000 | $10,636,000,000 | $10,360,000,000 | $10,057,000,000 |
| Expenses | ||||
| Interest Expense | $290,000,000 | $408,000,000 | $508,000,000 | $413,000,000 |
| Total Expenses | $11,067,000,000 | $10,197,000,000 | $9,653,000,000 | $10,090,000,000 |
| Other Income Expense | $-444,000,000 | $-387,000,000 | $-26,000,000 | $-2,821,000,000 |
| Other Non Operating Income Expenses | $51,000,000 | $60,000,000 | $54,000,000 | $42,000,000 |
| Net Non Operating Interest Income Expense | $-238,000,000 | $-341,000,000 | $-439,000,000 | $-394,000,000 |
| Interest Expense Non Operating | $290,000,000 | $408,000,000 | $508,000,000 | $413,000,000 |
| Operating Expense | $3,202,000,000 | $3,545,000,000 | $3,443,000,000 | $3,582,000,000 |
| Other Operating Expenses | $-206,000,000 | $-12,000,000 | $-28,000,000 | $35,000,000 |
| General And Administrative Expense | - | $2,967,000,000 | $3,938,000,000 | $3,097,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-900,000,000 | $-337,000,000 | $174,000,000 | $-3,125,000,000 |
| Net Interest Income | $-238,000,000 | $-341,000,000 | $-439,000,000 | $-394,000,000 |
| Interest Income | $52,000,000 | $67,000,000 | $69,000,000 | $19,000,000 |
| Normalized Income | $-508,950,000 | $16,130,000 | $233,840,000 | $-382,246,000 |
| Net Income From Continuing And Discontinued Operation | $-957,000,000 | $-649,000,000 | $2,656,000,000 | $-2,433,000,000 |
| Total Operating Income As Reported | $-308,000,000 | $14,000,000 | $707,000,000 | $-2,845,000,000 |
| Net Income Common Stockholders | $-957,000,000 | $-649,000,000 | $2,656,000,000 | $-2,433,000,000 |
| Net Income | $-957,000,000 | $-649,000,000 | $2,656,000,000 | $-2,433,000,000 |
| Net Income Including Noncontrolling Interests | $-957,000,000 | $-638,000,000 | $2,663,000,000 | $-2,421,000,000 |
| Net Income Discontinuous Operations | $-57,000,000 | $-312,000,000 | $2,482,000,000 | $692,000,000 |
| Net Income Continuous Operations | $-900,000,000 | $-326,000,000 | $181,000,000 | $-3,113,000,000 |
| Pretax Income | $-505,000,000 | $-289,000,000 | $242,000,000 | $-3,248,000,000 |
| Special Income Charges | $-478,000,000 | $-425,000,000 | $-34,000,000 | $-2,877,000,000 |
| Interest Income Non Operating | $52,000,000 | $67,000,000 | $69,000,000 | $19,000,000 |
| Operating Income | $177,000,000 | $439,000,000 | $707,000,000 | $-33,000,000 |
| Gross Profit | $3,379,000,000 | $3,984,000,000 | $4,150,000,000 | $3,549,000,000 |
| Per Share | ||||
| Diluted EPS | $-1.87 | $-1.27 | $5.25 | $-4.83 |
| Basic EPS | $-1.87 | $-1.27 | $5.25 | $-4.83 |
| Other | ||||
| Tax Effect Of Unusual Items | $-103,950,000 | $-93,870,000 | $-20,160,000 | $-120,246,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,261,000,000 | $1,563,000,000 | $1,814,000,000 | $1,100,000,000 |
| Total Unusual Items | $-495,000,000 | $-447,000,000 | $-80,000,000 | $-2,863,000,000 |
| Total Unusual Items Excluding Goodwill | $-495,000,000 | $-447,000,000 | $-80,000,000 | $-2,863,000,000 |
| Reconciled Depreciation | $981,000,000 | $997,000,000 | $984,000,000 | $1,072,000,000 |
| EBITDA (Bullshit earnings) | $766,000,000 | $1,116,000,000 | $1,734,000,000 | $-1,763,000,000 |
| EBIT | $-215,000,000 | $119,000,000 | $750,000,000 | $-2,835,000,000 |
| Diluted Average Shares | $513,000,000 | $510,000,000 | $506,000,000 | $504,000,000 |
| Basic Average Shares | $513,000,000 | $510,000,000 | $506,000,000 | $504,000,000 |
| Diluted NI Availto Com Stockholders | $-957,000,000 | $-649,000,000 | $2,656,000,000 | $-2,433,000,000 |
| Minority Interests | $0 | $-11,000,000 | $-7,000,000 | $-12,000,000 |
| Tax Provision | $395,000,000 | $37,000,000 | $61,000,000 | $-135,000,000 |
| Other Special Charges | $-16,000,000 | - | $1,000,000 | $54,000,000 |
| Write Off | $9,000,000 | $0 | $34,000,000 | $0 |
| Impairment Of Capital Assets | $485,000,000 | $425,000,000 | $0 | $2,812,000,000 |
| Gain On Sale Of Security | $-17,000,000 | $-22,000,000 | $-46,000,000 | $14,000,000 |
| Research And Development | $518,000,000 | $590,000,000 | $518,000,000 | $450,000,000 |
| Selling General And Administration | $2,890,000,000 | $2,967,000,000 | $2,953,000,000 | $3,097,000,000 |
| Gain On Sale Of Business | - | $0 | $0 | $-65,000,000 |
| Other Gand A | - | $2,967,000,000 | $3,938,000,000 | $3,097,000,000 |
| Restructuring And Mergern Acquisition | - | - | $-19,000,000 | $-39,000,000 |
| Salaries And Wages | - | - | $-42,000,000 | $-26,000,000 |
Fetched: 2026-06-14
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-3,169,000,000 | $-3,534,000,000 | $-3,309,000,000 | $-7,412,000,000 |
| Total Assets | $20,055,000,000 | $25,782,000,000 | $28,276,000,000 | $28,287,000,000 |
| Total Non Current Assets | $13,183,000,000 | $16,929,000,000 | $18,676,000,000 | $20,276,000,000 |
| Other Non Current Assets | $204,000,000 | $2,754,000,000 | $3,159,000,000 | $934,000,000 |
| Non Current Deferred Assets | $200,000,000 | $204,000,000 | $263,000,000 | $280,000,000 |
| Non Current Deferred Taxes Assets | $200,000,000 | $204,000,000 | $263,000,000 | $280,000,000 |
| Non Current Accounts Receivable | $126,000,000 | $132,000,000 | $154,000,000 | $211,000,000 |
| Goodwill And Other Intangible Assets | $9,298,000,000 | $10,498,000,000 | $11,711,000,000 | $13,245,000,000 |
| Other Intangible Assets | $4,369,000,000 | $5,223,000,000 | $5,918,000,000 | $6,793,000,000 |
| Current Assets | $6,872,000,000 | $8,853,000,000 | $9,600,000,000 | $8,011,000,000 |
| Other Current Assets | $481,000,000 | $328,000,000 | $286,000,000 | $368,000,000 |
| Hedging Assets Current | $0 | $8,000,000 | $45,000,000 | $14,000,000 |
| Assets Held For Sale Current | $0 | $2,611,000,000 | $2,179,000,000 | $236,000,000 |
| Prepaid Assets | $261,000,000 | $366,000,000 | $322,000,000 | $373,000,000 |
| Inventory | $2,232,000,000 | $2,046,000,000 | $1,918,000,000 | $2,679,000,000 |
| Receivables | $1,932,000,000 | $1,730,000,000 | $1,772,000,000 | $2,623,000,000 |
| Other Receivables | $71,000,000 | $51,000,000 | $53,000,000 | $52,000,000 |
| Accounts Receivable | $1,861,000,000 | $1,679,000,000 | $1,719,000,000 | $2,571,000,000 |
| Allowance For Doubtful Accounts Receivable | $-63,000,000 | $-71,000,000 | $-62,000,000 | $-114,000,000 |
| Gross Accounts Receivable | $1,924,000,000 | $1,750,000,000 | $1,781,000,000 | $2,685,000,000 |
| Cash Cash Equivalents And Short Term Investments | $1,966,000,000 | $1,764,000,000 | $3,078,000,000 | $1,718,000,000 |
| Cash And Cash Equivalents | $1,966,000,000 | $1,764,000,000 | $3,078,000,000 | $1,718,000,000 |
| Current Deferred Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $7,510,000,000 | $11,362,000,000 | $10,678,000,000 | $14,918,000,000 |
| Total Debt | $9,780,000,000 | $13,449,000,000 | $14,113,000,000 | $17,203,000,000 |
| Long Term Debt And Capital Lease Obligation | $9,696,000,000 | $10,617,000,000 | $11,354,000,000 | $15,679,000,000 |
| Long Term Debt | $9,473,000,000 | $10,374,000,000 | $11,089,000,000 | $15,232,000,000 |
| Current Debt And Capital Lease Obligation | $84,000,000 | $2,832,000,000 | $2,759,000,000 | $1,524,000,000 |
| Current Debt | $3,000,000 | $2,752,000,000 | $2,667,000,000 | $1,404,000,000 |
| Other Current Borrowings | $3,000,000 | $2,752,000,000 | $2,667,000,000 | $1,404,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $13,953,000,000 | $18,758,000,000 | $19,808,000,000 | $22,392,000,000 |
| Total Non Current Liabilities Net Minority Interest | $10,983,000,000 | $12,247,000,000 | $13,305,000,000 | $17,647,000,000 |
| Other Non Current Liabilities | $192,000,000 | $132,000,000 | $151,000,000 | $217,000,000 |
| Liabilities Heldfor Sale Non Current | $0 | $554,000,000 | $551,000,000 | $120,000,000 |
| Tradeand Other Payables Non Current | $146,000,000 | $94,000,000 | $72,000,000 | $64,000,000 |
| Non Current Deferred Liabilities | $281,000,000 | $143,000,000 | $444,000,000 | $701,000,000 |
| Non Current Deferred Taxes Liabilities | $245,000,000 | $103,000,000 | $403,000,000 | $661,000,000 |
| Current Liabilities | $2,970,000,000 | $6,511,000,000 | $6,503,000,000 | $4,745,000,000 |
| Other Current Liabilities | $127,000,000 | $1,042,000,000 | $1,121,000,000 | $161,000,000 |
| Current Deferred Liabilities | $141,000,000 | $131,000,000 | $128,000,000 | $154,000,000 |
| Payables And Accrued Expenses | $2,182,000,000 | $2,020,000,000 | $1,981,000,000 | $2,449,000,000 |
| Payables | $1,183,000,000 | $1,272,000,000 | $1,198,000,000 | $1,508,000,000 |
| Dividends Payable | $5,000,000 | $87,000,000 | $147,000,000 | $146,000,000 |
| Total Tax Payable | $179,000,000 | $217,000,000 | $170,000,000 | $252,000,000 |
| Income Tax Payable | $83,000,000 | $121,000,000 | $78,000,000 | $91,000,000 |
| Accounts Payable | $999,000,000 | $968,000,000 | $881,000,000 | $1,110,000,000 |
| Other Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $6,129,000,000 | $6,964,000,000 | $8,402,000,000 | $5,833,000,000 |
| Total Equity Gross Minority Interest | $6,102,000,000 | $7,024,000,000 | $8,468,000,000 | $5,895,000,000 |
| Stockholders Equity | $6,129,000,000 | $6,964,000,000 | $8,402,000,000 | $5,833,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-3,754,000,000 | $-4,010,000,000 | $-3,554,000,000 | $-3,833,000,000 |
| Other Equity Adjustments | $-3,754,000,000 | $-4,010,000,000 | $-3,554,000,000 | $-3,833,000,000 |
| Retained Earnings | $13,705,000,000 | $14,929,000,000 | $16,114,000,000 | $14,050,000,000 |
| Other | ||||
| Treasury Shares Number | $169,213,617 | $172,567,636 | $175,861,893 | $179,062,594 |
| Ordinary Shares Number | $514,281,327 | $510,927,308 | $507,633,051 | $504,432,350 |
| Share Issued | $683,494,944 | $683,494,944 | $683,494,944 | $683,494,944 |
| Tangible Book Value | $-3,169,000,000 | $-3,534,000,000 | $-3,309,000,000 | $-7,412,000,000 |
| Invested Capital | $15,605,000,000 | $20,090,000,000 | $22,158,000,000 | $22,469,000,000 |
| Working Capital | $3,902,000,000 | $2,342,000,000 | $3,097,000,000 | $3,266,000,000 |
| Capital Lease Obligations | $304,000,000 | $323,000,000 | $357,000,000 | $567,000,000 |
| Total Capitalization | $15,602,000,000 | $17,338,000,000 | $19,491,000,000 | $21,065,000,000 |
| Minority Interest | $-27,000,000 | $60,000,000 | $66,000,000 | $62,000,000 |
| Treasury Stock | $10,873,000,000 | $11,059,000,000 | $11,230,000,000 | $11,389,000,000 |
| Additional Paid In Capital | $6,368,000,000 | $6,421,000,000 | $6,389,000,000 | $6,322,000,000 |
| Capital Stock | $683,000,000 | $683,000,000 | $683,000,000 | $683,000,000 |
| Common Stock | $683,000,000 | $683,000,000 | $683,000,000 | $683,000,000 |
| Employee Benefits | $637,000,000 | $678,000,000 | $714,000,000 | $846,000,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $637,000,000 | $678,000,000 | $714,000,000 | $846,000,000 |
| Non Current Deferred Revenue | $36,000,000 | $40,000,000 | $41,000,000 | $40,000,000 |
| Long Term Capital Lease Obligation | $223,000,000 | $243,000,000 | $265,000,000 | $447,000,000 |
| Long Term Provisions | $31,000,000 | $29,000,000 | $19,000,000 | $20,000,000 |
| Current Deferred Revenue | $141,000,000 | $131,000,000 | $128,000,000 | $154,000,000 |
| Current Capital Lease Obligation | $81,000,000 | $80,000,000 | $92,000,000 | $120,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $436,000,000 | $486,000,000 | $514,000,000 | $457,000,000 |
| Current Accrued Expenses | $999,000,000 | $748,000,000 | $783,000,000 | $941,000,000 |
| Defined Pension Benefit | $66,000,000 | $56,000,000 | $46,000,000 | $123,000,000 |
| Investments And Advances | $103,000,000 | $109,000,000 | $136,000,000 | $247,000,000 |
| Goodwill | $4,929,000,000 | $5,275,000,000 | $5,793,000,000 | $6,452,000,000 |
| Net PPE | $3,186,000,000 | $3,176,000,000 | $3,207,000,000 | $5,236,000,000 |
| Accumulated Depreciation | $-5,144,000,000 | $-4,778,000,000 | $-4,779,000,000 | $-6,085,000,000 |
| Gross PPE | $8,330,000,000 | $7,954,000,000 | $7,986,000,000 | $11,321,000,000 |
| Construction In Progress | $704,000,000 | $718,000,000 | $624,000,000 | $909,000,000 |
| Other Properties | $651,000,000 | $773,000,000 | $1,096,000,000 | $2,154,000,000 |
| Machinery Furniture Equipment | $5,454,000,000 | $5,047,000,000 | $4,909,000,000 | $6,364,000,000 |
| Buildings And Improvements | $1,402,000,000 | $1,301,000,000 | $1,238,000,000 | $1,757,000,000 |
| Land And Improvements | $119,000,000 | $115,000,000 | $119,000,000 | $137,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,327,000,000 | $1,270,000,000 | $1,154,000,000 | $1,687,000,000 |
| Work In Process | $369,000,000 | $266,000,000 | $234,000,000 | $294,000,000 |
| Raw Materials | $536,000,000 | $510,000,000 | $530,000,000 | $698,000,000 |
Fetched: 2026-06-14
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $323,000,000 | $559,000,000 | $1,290,000,000 | $576,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $845,000,000 | $1,019,000,000 | $1,726,000,000 | $1,211,000,000 |
| Cash From Discontinued Operating Activities | $-106,000,000 | $200,000,000 | $519,000,000 | $683,000,000 |
| Cash Flow From Continuing Operating Activities | $951,000,000 | $819,000,000 | $1,207,000,000 | $528,000,000 |
| Operating Gains Losses | $-48,000,000 | $-28,000,000 | $-29,000,000 | $170,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-522,000,000 | $-460,000,000 | $-436,000,000 | $-635,000,000 |
| Investing Cash Flow | $2,841,000,000 | $-626,000,000 | $3,213,000,000 | $-931,000,000 |
| Cash From Discontinued Investing Activities | $3,305,000,000 | $-216,000,000 | $3,623,000,000 | $-307,000,000 |
| Cash Flow From Continuing Investing Activities | $-464,000,000 | $-410,000,000 | $-410,000,000 | $-624,000,000 |
| Net Other Investing Changes | $58,000,000 | $16,000,000 | $26,000,000 | $11,000,000 |
| Capital Expenditure Reported | $-513,000,000 | $-446,000,000 | $-432,000,000 | $-377,000,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-4,216,000,000 | $-1,081,000,000 | $-3,489,000,000 | $-1,438,000,000 |
| Cash Flow From Continuing Financing Activities | $-4,216,000,000 | $-1,081,000,000 | $-3,489,000,000 | $-1,438,000,000 |
| Net Other Financing Charges | $-107,000,000 | $-31,000,000 | $-63,000,000 | $-61,000,000 |
| Cash Dividends Paid | $-348,000,000 | $-590,000,000 | $-586,000,000 | $-573,000,000 |
| Common Stock Dividend Paid | $-348,000,000 | $-590,000,000 | $-586,000,000 | $-573,000,000 |
| Repurchase Of Capital Stock | - | $0 | $0 | $-32,000,000 |
| Net Common Stock Issuance | - | $0 | $0 | $-32,000,000 |
| Other | ||||
| Repayment Of Debt | $-5,789,000,000 | $-2,657,000,000 | $-2,935,000,000 | $-954,000,000 |
| Issuance Of Debt | $1,998,000,000 | $2,126,000,000 | $0 | $55,000,000 |
| Interest Paid Supplemental Data | $303,000,000 | $401,000,000 | $484,000,000 | $355,000,000 |
| End Cash Position | $1,968,000,000 | $2,414,000,000 | $3,198,000,000 | $1,722,000,000 |
| Beginning Cash Position | $2,414,000,000 | $3,198,000,000 | $1,722,000,000 | $2,956,000,000 |
| Effect Of Exchange Rate Changes | $84,000,000 | $-96,000,000 | $26,000,000 | $-76,000,000 |
| Changes In Cash | $-530,000,000 | $-688,000,000 | $1,450,000,000 | $-1,158,000,000 |
| Proceeds From Stock Option Exercised | $30,000,000 | $71,000,000 | $95,000,000 | $127,000,000 |
| Net Issuance Payments Of Debt | $-3,791,000,000 | $-531,000,000 | $-2,935,000,000 | $-899,000,000 |
| Net Short Term Debt Issuance | $-300,000,000 | $2,126,000,000 | $-301,000,000 | $55,000,000 |
| Short Term Debt Payments | $-300,000,000 | - | $-301,000,000 | - |
| Short Term Debt Issuance | $0 | $2,126,000,000 | $0 | $55,000,000 |
| Net Long Term Debt Issuance | $-3,491,000,000 | $-2,657,000,000 | $-2,634,000,000 | $-954,000,000 |
| Long Term Debt Payments | $-5,489,000,000 | $-2,657,000,000 | $-2,634,000,000 | $-954,000,000 |
| Long Term Debt Issuance | $1,998,000,000 | $0 | $0 | $0 |
| Net Investment Purchase And Sale | $0 | $34,000,000 | $0 | $0 |
| Sale Of Investment | $0 | $34,000,000 | $0 | $0 |
| Net Intangibles Purchase And Sale | $-9,000,000 | $-14,000,000 | $-4,000,000 | $-258,000,000 |
| Purchase Of Intangibles | $-9,000,000 | $-14,000,000 | $-4,000,000 | $-258,000,000 |
| Change In Working Capital | $-108,000,000 | $-236,000,000 | $161,000,000 | $-606,000,000 |
| Change In Other Working Capital | $-81,000,000 | $-31,000,000 | $-13,000,000 | $-91,000,000 |
| Change In Payables And Accrued Expense | $152,000,000 | $156,000,000 | $385,000,000 | $-225,000,000 |
| Change In Accrued Expense | $149,000,000 | $44,000,000 | $293,000,000 | $-158,000,000 |
| Change In Payable | $3,000,000 | $112,000,000 | $92,000,000 | $-67,000,000 |
| Change In Account Payable | $3,000,000 | $112,000,000 | $92,000,000 | $-67,000,000 |
| Change In Prepaid Assets | $72,000,000 | $-125,000,000 | $-45,000,000 | $-44,000,000 |
| Change In Inventory | $-119,000,000 | $-201,000,000 | $-128,000,000 | $-198,000,000 |
| Change In Receivables | $-132,000,000 | $-35,000,000 | $-38,000,000 | $-48,000,000 |
| Changes In Account Receivables | $-132,000,000 | $-35,000,000 | $-38,000,000 | $-48,000,000 |
| Other Non Cash Items | $30,000,000 | $41,000,000 | $62,000,000 | $-40,000,000 |
| Stock Based Compensation | $117,000,000 | $114,000,000 | $115,000,000 | $140,000,000 |
| Asset Impairment Charge | $802,000,000 | $519,000,000 | $-11,000,000 | $3,165,000,000 |
| Deferred Tax | $77,000,000 | $-262,000,000 | $-256,000,000 | $-260,000,000 |
| Deferred Income Tax | $77,000,000 | $-262,000,000 | $-256,000,000 | $-260,000,000 |
| Depreciation Amortization Depletion | $981,000,000 | $997,000,000 | $984,000,000 | $1,072,000,000 |
| Depreciation And Amortization | $981,000,000 | $997,000,000 | $984,000,000 | $1,072,000,000 |
| Amortization Cash Flow | $598,000,000 | $625,000,000 | $590,000,000 | $679,000,000 |
| Amortization Of Intangibles | $598,000,000 | $625,000,000 | $590,000,000 | $679,000,000 |
| Depreciation | $383,000,000 | $372,000,000 | $394,000,000 | $393,000,000 |
| Pension And Employee Benefit Expense | $-32,000,000 | $-28,000,000 | $-29,000,000 | $30,000,000 |
| Net Income From Continuing Operations | $-900,000,000 | $-326,000,000 | $181,000,000 | $-3,113,000,000 |
| Income Tax Paid Supplemental Data | - | $223,000,000 | $174,000,000 | $168,000,000 |
| Common Stock Payments | - | $0 | $0 | $-32,000,000 |
| Net Foreign Currency Exchange Gain Loss | - | $0 | $0 | $65,000,000 |
| Gain Loss On Sale Of Business | - | $0 | $0 | $75,000,000 |
| Net Business Purchase And Sale | - | - | $-6,000,000 | $-263,000,000 |
| Purchase Of Business | - | - | $-6,000,000 | $-263,000,000 |
Fetched: 2026-06-14